Class-Action Lawsuit Involving Belviq Weight-Loss Drug
According to a recent
class-action lawsuit, drug manufacturers Eisai, Inc. and Arena Pharmaceuticals,
Inc. failed to inform the Food & Drug Administration (FDA) about a 2007
study showing that its weight-loss drug Belviq (aka lorcaserin) caused
aggressive tumors in rats.The FDA approved Belviq in 2012 but
did...